Heart & Lung News
Novalung at ESCIM Paris 2018 – Session and Workshop Report
Novalung at ESCIM Paris 2018 Session and Workshop Report
VV ECMO in severe ARDS: EOLIA trial results show benefit for patients
The results of the ECMO to rescue lung injury in severe ARDS (EOLIA) trial have long been awaited, since the first two trials in this field were already conducted decades ago and the results were controversial. The investigators around Prof. Alain Combes showed now in the largest international randomized multicentre setup so far, that ...
Ten years of Academy – Xenios AG training programme celebrates its anniversary this year
Originally launched as Novalung Academy, present-day Xenios Academy is celebrating its tenth anniversary. With training courses, studies and clinical support, Xenios AG assists its customers in everyday clinic work in the field of extracorporeal lung and heart support. Having undergone many years of continuing development, the concept for knowledge ...
ESICM 2017
The 30th ESICM conference (ESICM LIVES 2017) was held in Vienna, Austria from 23–27 September 2017. This has become one of the largest and most prestigious gatherings of intensive care person-nel worldwide. Xenios AG actively participated by organizing the a simulation center during the opening hours, where interested professionals ...
STIMME Firmenlauf 2017, Heilbronn 27.07. – not the fastest team, but the winner of hearts.
ÖKG 2017, Salzburg
Our boost at ÖKG in Salzburg 2017: Xenios looks back on a very successful ÖKG in Salzburg. Especially the interest in our i-cor products was very high.